Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer

NCT03078400 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Epithelial Cancer

Interventions

DRUG: SPL-108

Sponsor

Splash Pharmaceuticals, Inc.